Literature DB >> 31901340

Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy.

Sanjeev Sethi1, Hanna Debiec2, Benjamin Madden3, M Cristine Charlesworth3, Johann Morelle4, LouAnn Gross5, Aishwarya Ravindran5, David Buob6, Michel Jadoul4, Fernando C Fervenza7, Pierre Ronco8.   

Abstract

Membranous nephropathy is characterized by deposition of immune complexes along the glomerular basement membrane. PLA2R and THSD7A are target antigens in 70% and 1-5% of primary membranous nephropathy cases, respectively. In the remaining cases, the target antigen is unknown. Here, laser microdissection of glomeruli followed by mass spectrometry was used to identify novel antigen(s) in PLA2R-negative membranous nephropathy. An initial pilot mass spectrometry study in 35 cases of PLA2R-negative membranous nephropathy showed high spectral counts for neural tissue encoding protein with EGF-like repeats, NELL-1, in six cases. Mass spectrometry failed to detect NELL-1 in 23 PLA2R-associated membranous nephropathy and 88 controls. NELL-1 was localized by immunohistochemistry, which showed bright granular glomerular basement membrane staining for NELL-1 in all six cases. Next, an additional 23 NELL-1 positive cases of membranous nephropathy were identified by immunohistochemistry in a discovery cohort of 91 PLA2R-negative membranous nephropathy cases, 14 were confirmed by mass spectrometry. Thus, 29 of 126 PLA2R-negative cases were positive for NELL-1. PLA2R-associated membranous nephropathy and controls stained negative for NELL-1. We then identified five NELL-1 positive cases of membranous nephropathy out of 84 PLA2R and THSD7A-negative cases in two validation cohorts from France and Belgium. By confocal microscopy, both IgG and NELL-1 co-localized to the glomerular basement membrane. Western blot analysis showed reactivity to NELL-1 in five available sera, but no reactivity in control sera. Clinical and biopsy findings of NELL-1 positive membranous nephropathy showed features of primary membranous nephropathy. Thus, a subset of membranous nephropathy is associated with accumulation and co-localization of NELL-1 and IgG along the glomerular basement membrane, and with anti-NELL-1 antibodies in the serum. Hence, NELL-1 defines a distinct type of primary membranous nephropathy.
Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NELL-1; mass spectrometry; membranous nephropathy

Mesh:

Substances:

Year:  2019        PMID: 31901340     DOI: 10.1016/j.kint.2019.09.014

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  71 in total

1.  DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity.

Authors:  Aili Cao; Jianhua Li; Morad Asadi; John M Basgen; Bingbing Zhu; Zhengzi Yi; Song Jiang; Tomohito Doke; Osama El Shamy; Niralee Patel; Paolo Cravedi; Evren U Azeloglu; Kirk N Campbell; Madhav Menon; Steve Coca; Weijia Zhang; Hao Wang; Ke Zen; Zhihong Liu; Barbara Murphy; John C He; Vivette D D'Agati; Katalin Susztak; Lewis Kaufman
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

Review 2.  Immunopathogenesis of idiopathic nephrotic syndrome in children: two sides of the coin.

Authors:  Jing Chen; Xiao-Hui Qiao; Jian-Hua Mao
Journal:  World J Pediatr       Date:  2021-03-03       Impact factor: 2.764

3.  Membranous nephropathy with masked polyclonal IgG deposits associated with primary Sjögren's syndrome.

Authors:  Kiyotaka Nagahama; Aya Isomura; Hiroaki Shimoyamada; Shintaro Masuko; Sachiko Shimoda; Miho Karube; Yoshinori Komagata; Shinya Kaname; Junji Shibahara
Journal:  CEN Case Rep       Date:  2020-08-07

4.  NELL1 is a target antigen in malignancy-associated membranous nephropathy.

Authors:  Tiffany N Caza; Samar I Hassen; Zeljko Dvanajscak; Michael Kuperman; Rick Edmondson; Christian Herzog; Aaron Storey; John Arthur; L Nicholas Cossey; Shree G Sharma; Daniel J Kenan; Christopher P Larsen
Journal:  Kidney Int       Date:  2020-08-20       Impact factor: 10.612

5.  Growing Understanding of the Antigenic Basis for Membranous Nephropathy.

Authors:  Vesna Brglez; Barbara Seitz-Polski
Journal:  Clin J Am Soc Nephrol       Date:  2021-04-13       Impact factor: 8.237

6.  Neural Epidermal Growth Factor-Like 1 Protein-Positive Membranous Nephropathy in Chinese Patients.

Authors:  Guoqin Wang; Lijun Sun; Hongrui Dong; Yanyan Wang; Xiaoyi Xu; Zhirui Zhao; Wenrong Cheng; Xuejiao Liu; Xiaoyi Zhao; Yanqiu Geng; Siqin Bao; Yipu Chen; Hong Cheng
Journal:  Clin J Am Soc Nephrol       Date:  2021-04-13       Impact factor: 8.237

7.  Protocadherin 7-Associated Membranous Nephropathy.

Authors:  Sanjeev Sethi; Benjamin Madden; Hanna Debiec; Johann Morelle; M Cristine Charlesworth; LouAnn Gross; Vivian Negron; David Buob; Sidharth Chaudhry; Michel Jadoul; Fernando C Fervenza; Pierre Ronco
Journal:  J Am Soc Nephrol       Date:  2021-04-08       Impact factor: 10.121

Review 8.  Segmental membranous nephropathy.

Authors:  Hae Yoon Grace Choung; Bruce Goldman
Journal:  Clin Exp Nephrol       Date:  2021-03-23       Impact factor: 2.801

9.  Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial.

Authors:  Francesco Scolari; Elisa Delbarba; Domenico Santoro; Loreto Gesualdo; Antonello Pani; Nadia Dallera; Laila-Yasmin Mani; Marisa Santostefano; Sandro Feriozzi; Marco Quaglia; Giuliano Boscutti; Angelo Ferrantelli; Carmelita Marcantoni; Patrizia Passerini; Riccardo Magistroni; Federico Alberici; Gian Marco Ghiggeri; Claudio Ponticelli; Pietro Ravani
Journal:  J Am Soc Nephrol       Date:  2021-03-01       Impact factor: 10.121

Review 10.  New 'Antigens' in Membranous Nephropathy.

Authors:  Sanjeev Sethi
Journal:  J Am Soc Nephrol       Date:  2020-12-30       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.